Definitive Healthcare (NASDAQ:DH) Issues Q4 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its fourth quarter 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 0.070-0.070 for the period, compared to the consensus EPS estimate of 0.070. The company issued revenue guidance of $60.0 million-$61.0 million, compared to the consensus revenue estimate of $60.3 million. Definitive Healthcare also updated its FY 2024 guidance to 0.340-0.350 EPS.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on DH. Barclays dropped their target price on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. BTIG Research assumed coverage on shares of Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective on the stock. Morgan Stanley lowered their price objective on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Friday. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $5.81.

Definitive Healthcare Price Performance

Shares of NASDAQ DH traded down $0.07 during midday trading on Friday, reaching $4.24. The stock had a trading volume of 1,200,343 shares, compared to its average volume of 326,752. The stock has a 50-day moving average of $4.36 and a 200-day moving average of $4.98. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.40 and a current ratio of 2.40. The company has a market capitalization of $500.02 million, a price-to-earnings ratio of -1.22, a price-to-earnings-growth ratio of 6.27 and a beta of 1.33. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $10.62.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.